This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

ResolvedTier 3 — Critical

UROMITEXAN

BAXTER CORPORATION

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of UROMITEXAN in Canada?

Yes. UROMITEXAN 100MG has an active shortage reported to Health Canada (last updated October 6, 2026).

Why is UROMITEXAN not available?

The reason the manufacturer reported: Demand increase for the drug.

When will UROMITEXAN be available again?

The estimated resolution date (October 31, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength100MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02241411

Strength

100MG

Dosage Form

SOLUTION

Route

ORAL INTRAVENOUS

Active Ingredient

MESNA

Tier

Tier 3 — Critical

Last Updated

2026-10-27

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

UROMITEXAN has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-06

Active Shortage

Demand increase for the drug.

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217